Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Bortezomib

2

X.n Tumor lysis syndrome (TLS)

1
Last update : 09/07/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Tumor lysis syndrome early after treatment with bortezomib for multiple myeloma.
Pharmacotherapy 2006 Aug;26;1205-6; discussion 1206 2006 Aug
Tumor lysis syndrome after bortezomib therapy for plasma cell leukemia.
Pharmacotherapy 2005 Dec;25;1820-5 2005 Dec
Tumour lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration.
Journal of cancer research and clinical oncology 2004 Oct;130;623-5 2004 Oct

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies